项目编号：DT-BD-20200411-007
Project Number: DT-BD-20200411-007
Request: European and American companies would like to license in innovative drugs from companies in China
目标领域：全部疾病领域和适应症，只要足够创新
Target area: All therapeutic areas and indications, as long as the drugs are innovative enough
目标阶段：不限
Target stage: all stages, as long as the drugs are innovative enough
药物类别：小分子药或者生物药均可
Drug category: small molecule drugs or biological drugs
目标权益：中国大陆或大中华区之外
Target right: Ex-China, Ex-Greater China
如果您对该合作机会感兴趣，欢迎与我们联系！我们将与您详细探讨。谢谢！
If you are interested in introducing this collaboration opportunity, please contact us. We will discuss with you in details. Thank you very much!
联系人 (Contact)：Will
电话 (Mobile)：13564569657
微信 (Wechat)：27674131
邮箱 (E-mail)：BD@drugtimes.cn
邮件主题请注明：项目编号：DT-BD-20200411-007
In the e-mail subject, please include “Project Number: DT-BD-20200411-007”
发布者：DrugTimes001，转载请首先联系contact@drugtimes.cn获得授权
为好文打赏 支持药时代 共创新未来！ 